The Patent Finder

Ase & Bio

Also on record
Records under this name other than patents Ase & Bio holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 2 of 2 · Back to Ase & Bio

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,367,641Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them
Lapsed on the fee record
Ended Feb 5, 2017 · USPTO record
Lapsed on the fee recordEnded Feb 5, 2017USPTO record
US 8,288,363Medicaments for anti-herpes virus treatments
Lapsed on the fee record
Ended Oct 16, 2016 · USPTO record
Lapsed on the fee recordEnded Oct 16, 2016USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited